Yan Zhang1, Chunxia Qiao2, Lian Li3, Xuye Zhao4, Yali Li1. 1. Department of Gynecology and Obstetrics, the Chinese PLA General Hospital. 2. Laboratory of Immunology, Institute of Basic Medical Sciences. 3. Department of Microbiology, College of Medical Sciences, Inner Mongolia Medical University. 4. Department of Gynecology and Obstetrics, Shanxi Tumor Hospital.
Abstract
OBJECTIVE: This study measured the human epididymis protein 4 (HE4) and CA125 levels in Chinese women with benign gynecological disorders. MATERIAL AND METHODS: Sera were obtained from Chinese women prior to surgery for a pelvic mass and HE4 and CA125 levels were determined. The proportions of patients with HE4 and CA125 levels were compared. RESULTS: There were 68 Chinese women with benign diseases. HE4 levels were less elevated than CA125 (1% V.S. 29%, P<0.001). The significant difference was observed in patients with endometriosis/endometriomas in which HE4 was not elevated patients and CA125 was elevated in 53% (P<0.001). Serum HE4 level was not elevated in patients with cystadenoma (0% V.S. 23%, P<0.001) and in patients with germ cell tumors (0% V.S. 5%, P<0.001). CONCLUSION: HE4 was less elevated and more suitable as a biomarker than CA125 in chinese women with benign disease.
OBJECTIVE: This study measured the human epididymis protein 4 (HE4) and CA125 levels in Chinese women with benign gynecological disorders. MATERIAL AND METHODS: Sera were obtained from Chinese women prior to surgery for a pelvic mass and HE4 and CA125 levels were determined. The proportions of patients with HE4 and CA125 levels were compared. RESULTS: There were 68 Chinese women with benign diseases. HE4 levels were less elevated than CA125 (1% V.S. 29%, P<0.001). The significant difference was observed in patients with endometriosis/endometriomas in which HE4 was not elevated patients and CA125 was elevated in 53% (P<0.001). Serum HE4 level was not elevated in patients with cystadenoma (0% V.S. 23%, P<0.001) and in patients with germ cell tumors (0% V.S. 5%, P<0.001). CONCLUSION:HE4 was less elevated and more suitable as a biomarker than CA125 in chinese women with benign disease.
Authors: Craig C Earle; Deborah Schrag; Bridget A Neville; K Robin Yabroff; Marie Topor; Angela Fahey; Edward L Trimble; Diane C Bodurka; Robert E Bristow; Michael Carney; Joan L Warren Journal: J Natl Cancer Inst Date: 2006-02-01 Impact factor: 13.506
Authors: Li Dong; Xiao-Hong Chang; Xue Ye; Li-Rong Zhu; Yang Zhao; Li Tian; Hong-Yan Cheng; Xiao-Ping Li; Hong Zhang; Qin-Ping Liao; Tian-Yun Fu; Ye-Xia Cheng; Heng Cui Journal: Zhonghua Fu Chan Ke Za Zhi Date: 2008-12
Authors: R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp Journal: N Engl J Med Date: 1983-10-13 Impact factor: 91.245
Authors: Elham O Hamed; Hydi Ahmed; Osama B Sedeek; Abeer M Mohammed; Ali A Abd-Alla; Hazem M Abdel Ghaffar Journal: Diagn Pathol Date: 2013-01-23 Impact factor: 2.644